XML 34 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
3 Months Ended
Aug. 01, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

14. Stock-Based Compensation

Equity Incentive Plan Description

On September 16, 2015, our shareholders approved an equity incentive plan titled the Culp, Inc. 2015 Equity Incentive Plan (the “2015 Plan”). The 2015 Plan authorizes the grant of stock options intended to qualify as incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and other equity and cash related awards as determined by our Compensation Committee. An aggregate of 1,200,000 shares of common stock were authorized for issuance under the 2015 Plan, with certain sub-limits that would apply with respect to specific types of awards that may be issued as defined in the 2015 Plan.

As of August 1, 2021, there were 474,575 shares available for future equity-based grants under the 2015 Plan.

Performance-Based Restricted Stock Units

Senior Executives

We have granted performance-based restricted stock units to senior executives which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit agreements. The number of shares of common stock that are earned based on performance targets that have been achieved may be adjusted based on a market-based total shareholder return component as defined in the related restricted stock unit agreements.

Our performance-based restricted stock units granted to senior executives were measured based on their fair market value on the date of grant. The fair market value per share was determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock for the performance-based component.   

Key Employees

We have granted performance-based restricted stock units which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit agreements. Our performance-based restricted stock units granted to key employees were measured based on the fair market value (the closing price of our common stock) on the date of grant. No market-based total shareholder return component was included in these awards.

Overall

The following table summarizes information related to our grants of performance-based restricted stock units associated with senior executives and key employees that are unvested as of August 1, 2021:

 

 

 

(3)

 

 

(4)

 

 

 

 

 

 

 

 

 

 

Performance-Based

 

 

Restricted Stock

 

 

 

 

 

 

 

 

 

 

Restricted Stock

 

 

Units Expected

 

 

 

 

 

 

 

 

Date of Grant

 

Units Awarded

 

 

to Vest

 

 

Price Per Share

 

 

 

Vesting Period

July 22, 2021 (1)

 

 

122,477

 

 

 

61,237

 

 

$

14.75

 

(6)

 

3 years

July 22, 2021 (2)

 

 

21,900

 

 

 

10,950

 

 

$

14.75

 

(6)

 

3 years

July 18, 2019 (1)

 

 

93,653

 

 

 

5,749

 

 

$

19.04

 

(5)

 

3 years

July 18, 2019 (2)

 

 

29,227

 

 

 

3,442

 

 

$

18.49

 

(6)

 

3 years

 

(1)

Performance-based restricted stock units awarded to senior executives.

(2)

Performance-based restricted stock units awarded to key employees.

 

(3)

Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.

(4)

Compensation cost is based on an assessment each reporting period to determine the probability of whether or not certain performance goals will be met and how many shares are expected to be earned as of the end of the vesting period. These amounts represent the number of shares that were expected to vest as of August 1, 2021.

(5)

Price per share represents the fair market value per share ($1.03 per $1, or an increase of $0.55 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($18.49) for the performance-based component of the performance-based restricted stock units granted to senior executives on July 18, 2019.

(6)

Price per share represents the closing price of our common stock on the date of grant.

The following table summarizes information related to our performance-based restricted stock units that vested during the three-month periods ending August 1, 2021, and August 2, 2020:

 

 

 

Performance-Based

 

 

 

 

 

 

(4)

 

 

 

Restricted Stock

 

 

(3)

 

 

Price

 

Fiscal Year

 

Units Vested

 

 

Fair Value

 

 

Per Share

 

Fiscal 2022 (1)

 

 

6,734

 

 

$

115

 

 

$

17.14

 

Fiscal 2022 (2)

 

 

5,812

 

 

$

100

 

 

$

17.14

 

Fiscal 2021 (1)

 

 

3,277

 

 

$

33

 

 

$

9.96

 

Fiscal 2021 (2)

 

 

3,710

 

 

$

37

 

 

$

9.96

 

 

(1)

Performance-based restricted stock units vested by senior executives.

(2)

Performance-based restricted stock units vested by key employees.

(3)

Dollar amounts are in thousands.

(4)

Price per share is derived from the closing price of our common stock on the date the respective performance-based restricted stock units vested.

We recorded a charge or a (credit) to compensation expense of $20,000 and $(11,000) within selling, general, and administrative expenses for the three-month periods ending August 1, 2021, and August 2, 2020, respectively. Compensation cost is recorded based on an assessment each reporting period to determine the probability of whether or not certain performance targets will be met and how many shares are expected to be earned as of the end of the vesting period. If certain performance goals are not expected to be achieved, compensation cost would not be recorded, and any previously recognized compensation cost would be reversed.

As of August 1, 2021, the remaining unrecognized compensation cost related to our performance-based restricted stock units was $1.1 million, which is expected to be recognized over a weighted average vesting period of 2.8 years. As of August 1, 2021, the performance-based restricted stock units that were expected to vest had a fair value totaling $1.1 million.

Time-Based Restricted Stock Units

The following table summarizes information related to our grants of time-based restricted stock unit awards associated with senior executives and key members of management that are unvested as of August 1, 2021:

 

 

 

Time-Based

 

 

 

 

 

 

 

 

 

 

Restricted Stock

 

 

(1)

 

 

 

 

Date of Grant

 

Units Awarded

 

 

Price Per Share

 

Vesting Period

July 22, 2021

 

 

38,289

 

 

$

14.75

 

 

 

3 years

August 6, 2020

 

 

129,896

 

 

$

11.01

 

 

 

3 years

July 18, 2019

 

 

34,399

 

 

$

18.49

 

 

 

3 years

August 2, 2018

 

 

10,000

 

 

$

24.35

 

 

 

5 years

 

(1)

Price per share represents closing price of common stock on the date the respective award was granted.

 

 

Overall

We recorded compensation expense of $184,000 and $67,000 within selling, general, and administrative expenses associated with our time-based restricted stock unit awards for the three-month periods ending August 1, 2021, and August 2, 2020, respectively.

As of August 1, 2021, the remaining unrecognized compensation cost related to our time-based restricted stock units was $1.8 million, which is expected to be recognized over a weighted average vesting period of 1.3 years. As of August 1, 2021, the time-based restricted stock units that are expected to vest had a fair value totaling $3.2 million.

Common Stock Award

We granted a total of 4,312 shares of common stock to our outside directors on July 1, 2021. These shares of common stock vested immediately and were measured at their fair value on the date of grant. The fair value of these awards was $16.24 per share on July 1, 2021, which represents the closing price of our common stock on the date of grant.

We granted a total of 7,000 shares of common stock to our outside directors on July 1, 2020. These shares of common stock vested immediately and were measured at their fair value on the date of grant. The fair value of these awards was $10.00 per share on July 1, 2020 which represents the closing price of our common stock on the date of grant.

We recorded $70,000 of compensation expense within selling, general, and administrative expenses for common stock awards to our outside directors for each of the three-month periods ending August 1, 2021, and August 2, 2020.